6-Chloro-2-iodopurine-9-riboside
9H-Purine, 6-chloro-2-iodo-9-β-D-ribofuranosyl- (6-CHLORO-2-IODOPURINE-9-RIBOSIDE) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[313477-85-9]
UNSPSC
12352005
Hazard Statement
H302-H315-H320-H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/6-chloro-2-iodopurine-9-riboside.html
Solubility
10 mM in DMSO
Smiles
ClC1=C(N=CN2[C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)C2=NC(I)=N1
Molecular Formula
C10H10ClIN4O4
Molecular Weight
412.57
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
RNF139 (E3 Ubiquitin-Protein Ligase RNF139, 632-, RING Finger Protein 139, Translocation in renal Carcinoma on Chromosome 8 Protein, RNF139) (MaxLight 405)
RNF139 (E3 Ubiquitin-Protein Ligase RNF139, 632-, RING Finger Protein 139, Translocation in renal Carcinoma on Chromosome 8 Protein, RNF139) (MaxLight 405)
Hadh sgRNA CRISPR Lentivector (Mouse) (Target 1)
